Compare HALO & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | PNFP |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 7.8B |
| IPO Year | 2001 | N/A |
| Metric | HALO | PNFP |
|---|---|---|
| Price | $67.28 | $88.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 16 |
| Target Price | $78.18 | ★ $112.20 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.21% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.56 | N/A |
| Revenue | ★ $151,862,000.00 | N/A |
| Revenue This Year | $28.24 | $163.66 |
| Revenue Next Year | $12.79 | $7.77 |
| P/E Ratio | $26.21 | ★ $12.24 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.50 | $81.57 |
| 52 Week High | $82.22 | $120.39 |
| Indicator | HALO | PNFP |
|---|---|---|
| Relative Strength Index (RSI) | 35.07 | 36.27 |
| Support Level | $62.97 | $83.62 |
| Resistance Level | $68.00 | $90.97 |
| Average True Range (ATR) | 2.37 | 3.39 |
| MACD | -0.79 | -0.82 |
| Stochastic Oscillator | 6.69 | 17.24 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.